Cholangiocarcinoma, also known as bile duct cancer, is a rare disease. It's a devastating condition incurable at the point where it's diagnosed, which can be late given the small number of bile duct ...

ATG-022 (Claudin 18.2 antibody-drug conjugate) Title: Phase I/II study of Claudin 18.2 ADC ATG-022 in patients with advanced gastric/ gastroesophageal junction cancer (CLINCH) Abstract Number: 2907 ...

With a baby on the way, Nathan Kirkland was facing a rare, aggressive form of bile duct cancer. Kirkland’s bills piled up as ...

The albumin-bilirubin (ALBI) score can independently predict prognosis in post-surgical patients with distal cholangiocarcinoma (dCCA), a form of cholangiocarcinoma (CCA), according to results ...

Adjuvant camrelizumab and concurrent chemoradiotherapy can improve outcomes in patients with gallbladder cancer and extrahepatic cholangiocarcinoma.

本研究利用20K人类蛋白质组芯片技术，成功鉴定出DCDC2作为肝内胆管癌（ICC）的新型肿瘤相关抗原（TAA），并揭示了其在肿瘤进展和免疫逃逸中的关键作用。通过抗体芯片的广谱筛选，研究发现ICC患者血清中抗DCDC2自身抗体水平显著升高，表明其作为潜 ...

Recursion Pharmaceuticals RXRX and Relay Therapeutics RLAY are pioneering the use of artificial intelligence (AI) in drug ...

作者：刘辉&罗素素你可能听过这样一句话：“癌症不是一天长成的。”这句话放在胆管癌身上再恰当不过，不是突然来袭，而是长期隐匿地埋伏在胆道的慢性炎症中，一点点积累细胞损伤，最终悄然变脸。今天，我们就来揭开胆管癌的前世今生，到底是怎么一步步变出来的？一、胆 ...

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor ...

The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...

A new study has uncovered a distinct pattern of immune-related genes in hepatobiliary cancers, setting them apart from other gastrointestinal tumors.